Dendritic cell subsets in blood and lymphoid tissue of rhesus monkeys and their mobilization with Flt3 ligand

We provide phenotypic and functional evidence of premonocytoid dendritic cells (DCs) and preplasmacytoid DCs in blood and of corresponding DC subsets in secondary lymphoid tissue of rhesus monkeys. Subsets were identified and sorted by 4-color flow cytometry using antihuman monoclonal antibodies cross-reactive with rhesus monkey. To mobilize pre-DC subsets, fms-like tyrosine 3 kinase ligand (Flt3L; 100 mug/kg subcutaneously) was administered for 10 days. Presumptive pre-DC subsets were identified within the lineage(-) (Lin(-)) major histocompatibility complex (MHC) class II+ fraction of blood mononuclear cells. Premonocytoid DCs were CD11c(+)CD123(-) (interleukin-3Ralpha(-) [IL-3Ralpha(-)]). Preplasmacytoid DCs were characterized as CD11c(-)CD123(++). Flt3L increased the CD11c(+) pre-DC (7-fold) and CD123(++) pre-DC subsets (3-fold) in blood. The freshly isolated CD11c+ pre-DC subset induced modest proliferation of naive allogeneic T cells. After overnight culture with granulocyte macrophage-colony-stimulating factor (GM-CSF) and CD40L, both subsets up-regulated surface costimulatory molecules, and CD11c(+) pre-DCs became potent allostimulators. Freshly isolated CD123(++) pre-DCs showed typical plasmacytoid morphology and, when cultured with IL-3 and CD40L for 72 hours, developed mature DC morphology. Following stimulation with CD40L, CD11c(+) pre-DCs secreted increased levels of IL-12p40. Importantly, herpes simplex virus-stimulated CD123(++) pre-DCs, but not CD11c(+) pre-DCs, secreted interferon-alpha (IFN-alpha). Corresponding DC subsets were identified by flow analysis and immunohistochemistry in lymph nodes wherein both populations were increased 2- to 3-fold by Flt3L administration. CD123(+) pre-DCs produced IFN-alpha in response to in vivo viral infection. Thus, rhesus monkeys exhibit 2 distinct DC precursor populations that closely resemble those of humans. Both are mobilized into blood and lymphoid tissue by Flt3L, offering potential for their further characterization and possible therapeutic application. (C) 2003 by The American Society of Hematology.